Citigroup Inc Adaptive Biotechnologies Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Citigroup Inc holds 108,541 shares of ADPT stock, worth $509,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,541

Previous 61,006 77.92%

Holding current value

$509,057

Previous $220,000 152.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.37 - $5.12 $160,192 - $243,379	47,535 Added 77.92%	108,541 $555,000
Q2 2024 Aug 12, 2024	SELL	$2.34 - $3.96 $187,003 - $316,467	-79,916 Reduced 56.71%	61,006 $220,000
Q1 2024 May 10, 2024	BUY	$2.88 - $4.8 $329,964 - $549,940	114,571 Added 434.79%	140,922 $452,000
Q4 2023 Feb 09, 2024	BUY	$3.46 - $5.33 $67,483 - $103,956	19,504 Added 284.85%	26,351 $129,000
Q3 2023 Nov 09, 2023	SELL	$5.07 - $8.44 $190,459 - $317,057	-37,566 Reduced 84.58%	6,847 $37,000
Q2 2023 Aug 10, 2023	BUY	$6.19 - $8.78 $212,533 - $301,461	34,335 Added 340.69%	44,413 $298,000
Q1 2023 May 11, 2023	SELL	$7.8 - $10.11 $20,670 - $26,791	-2,650 Reduced 20.82%	10,078 $88,000
Q4 2022 Feb 09, 2023	SELL	$6.26 - $9.34 $8,945 - $13,346	-1,429 Reduced 10.09%	12,728 $97,000
Q3 2022 Nov 10, 2022	SELL	$6.5 - $12.67 $74,405 - $145,033	-11,447 Reduced 44.71%	14,157 $101,000
Q2 2022 Aug 10, 2022	SELL	$6.4 - $14.73 $17,734 - $40,816	-2,771 Reduced 9.77%	25,604 $207,000
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $40,955 - $116,958	4,047 Added 16.64%	28,375 $394,000
Q4 2021 Feb 10, 2022	SELL	$25.17 - $36.85 $147,194 - $215,498	-5,848 Reduced 19.38%	24,328 $683,000
Q3 2021 Nov 10, 2021	BUY	$30.02 - $39.87 $905,883 - $1.2 Million	30,176 New	30,176 $1.03 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account